Skip to content

Zeiss RESIGHT Disposable Lenses Evaluation Study

Zeiss RESIGHT Disposable Lenses Evaluation Study: Investigator-initiated, Mono-center, Academic, Prospective, Interventional Case Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05860985
Acronym
RESIGHT
Enrollment
120
Registered
2023-05-16
Start date
2023-04-11
Completion date
2024-07-31
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular Holes, Macular Pucker, Retinal Detachment, Vitreomacular Traction

Brief summary

To evaluate the intra-operative efficacy of a new intra-operative viewing device.

Detailed description

This study is designed to obtain more information on the efficacy of the disposable RESIGHT lenses in routine vitrectomy surgery. This information can lead to adjustments to these surgical lenses to further fine tune a device which can be used by other surgeons. Theoretically, both the improved lens design and better resistance to fogging should improve the visualization of the retina hence facilitate the surgery, increasing the surgical safety.

Interventions

DEVICEZEISS disposable

a comparison will be done between the present lenses used (reusable RESIGHT lenses and disposable Vitreq contact lens) and the new disposable RESIGHT lenses.

Sponsors

Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures * Patients that are scheduled for primary vitrectomy surgery to treat retinal detachment or macular disease (pucker, macular hole, vitreomacular traction). * Both vitrectomy-only and combined phaco-vitrectomy surgeries * General or local anesthesia, or combination

Exclusion criteria

* Patient who do not have sufficient command of the Dutch language to read and understand the informed consent form * Any disorder, which in the investigator's opinion might jeopardise participant's safety or compliance with the CIP. * Repeat vitrectomy surgery

Design outcomes

Primary

MeasureTime frameDescription
Ultra Wide Field lens View Angle evaluationduring surgeryUltra Wide Field lens View Angle: scale from 1 (far more indentation) to 5 (far less indentation)
Ultra Wide Field lens Condensation evaluationduring surgeryUltra Wide Field lens Condensation: scale from 1 (far more condensation) to 5 (far less condensation)
Wide Angle lens Condensation evaluationduring surgeryWide Angle lens Condensation: scale from 1 (far more condensation ) to 5 (far less condensation)
Illumination appearance evaluationduring surgeryIllumination intensity required during the surgery : scale from 1 (significantly higher) to 5 (significantly lower)
Color appearance evaluationduring surgerycolor appearance during the surgery : scale from 1 (far less natural colors) to 5 (far better natural colors )

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026